Industry & policy
TodayMon 5 OctMonday 5 October2 papers
American Journal of Preventive CardiologyHumans
Changes in statin therapy eligibility under the 2026 versus 2018 dyslipidemia guidelines
YesterdaySun 4 OctSunday 4 October1 paper
Fri 2 Oct7 papers
Advances in Clinical and Experimental MedicineReview
Diet and nutrition in obesity treated with incretin-based therapies: A scientific statement of the Polish Society of Dietetics
International Journal of StrokeReview
International Modified Delphi Consensus on Assessment and Management of Covert Brain Infarction
Clinical Gastroenterology and HepatologyReview
AGA Clinical Practice Update on Surveillance of Pancreatic Cystic Lesions and Hepatocellular Carcinoma in Older Adults: Expert Review
Hellenic Journal of CardiologyReview
The EU Safe Hearts Plan and Greece: implementation considerations and opportunities
Thu 1 Oct4 papers
Korean Journal of Family MedicineReview
Smoking cessation policy gaps in South Korea: an MPOWER Framework analysis with AI-assisted multi-source evidence synthesis (2021-2026)
The American Journal of GastroenterologyReview
Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
Gastrointestinal EndoscopyReview
Serrated Polyposis Syndrome: A Review and Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer
Wed 30 Sep7 papers
Canadian Agency for Drugs and Technologies in Health, OttawaReview
Empagliflozin: Reimbursement Recommendation
Canadian Agency for Drugs and Technologies in Health, OttawaReview
Tirzepatide (Zepbound): Indication: For once-weekly administration for chronic weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity, in adults with an initial body mass index of: 30 kg/m2 or greater (obesity), or 27 kg/m2 to less than 30 kg/m2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, prediabetes, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease): Reimbursement Recommendation
Tue 29 Sep3 papers
Interactive Journal of Medical ResearchIn silico
The Shifting Landscape of Natural Health Product Licensing in Canada: The e-Commerce Case of Stem Cell Supplements
Mon 28 Sep5 papers
Public Health NursingReview
Living Longer after Labor Market Exit: Making Functional Healthspan a Public Health Nursing Priority
Australian and New Zealand Journal of Public HealthResearch
Embedding smoking cessation into lung cancer screening: Priorities of national expert stakeholders in Australia using a modified nominal group technique
Sat 26 Sep6 papers
Nature Reviews NephrologyReview
Recommendations for the management of frailty in chronic kidney disease: a consensus report
History and Philosophy of the Life SciencesReview
Benefit assessment of anti-ageing medicines in the European Union: regulatory obstacles and pluralistic alternatives
